| BSDLB | block in anterosuperior division of left branch |
|---|---|
| CHB | chronic hepatitis B; complete heart block; congenital heart block |
| SAB | Scientific Advisory Board; serum albumin; significant asymptomatic bacteriuria; sinoatrial block; So... |
| BD | barbital-dependent; barbiturate dependence; base deficit; base of prism down; basophilic degeneratio... |
| TD | tabes dorsalis; tardive dyskinesia; T-cell dependent; temporary disability; terminal device; tetanus... |
| androgen-dependent secretory protease | <enzyme> Glycoprotein from dog prostate; hydrolyzes arginine and lysine-containing amide and ester protease substrates Registry number: EC 3.4.99.- Synonym: ads-protease (26 Jun 1999) |
|---|---|
| anterograde block | Conduction block of an impulse traveling anywhere in its ordinary direction, for example, from the sinoatrial node toward the ventricular myocardium. (05 Mar 2000) |
| antibody-dependent cell cytotoxicity | The phenomenon of antibody-mediated target cell destruction by non-sensitised effector cells. The identity of the target cell varies, but it must possess surface IgG whose fc portion is intact. The effector cell is a "killer" cell possessing fc receptors. It may be a lymphocyte lacking conventional b- or T-cell markers, or a monocyte, macrophage, or polynuclear leukocyte, depending on the identity of the target cell. The reaction is complement-independent. (12 Dec 1998) |
| antibody-dependent enhancement | Enhancement of viral infectivity caused by non-neutralizing antibodies. There are at least two mechanisms known to account for this: mediation by fc receptors (receptors, fc) or by complement receptors (receptors, complement). Either the virus is complexed with antiviral IgG and binds to fc receptors, or virus is coated with antiviral IgM and binds to complement receptors. (12 Dec 1998) |
| arborization block | Intraventricular block supposedly due to widespread blockage in the Purkinje ramifications and manifested in the electrocardiogram by a pattern similar to bundle-branch block but with complexes of low amplitude. (05 Mar 2000) |
| aromatic NADH-dependent nitroreductase | <enzyme> See also record for 1-nitroreductase; type I nitroreductase is not inhibited by oxygen Registry number: EC 1.- Synonym: nitrofuran reductase, nitrofurazone reductase, type I nitroreductases, NADH-dependent nitro reductase, nitrofurantoin reductase, p-dinitrobenzene reductase, benznidazole nitroreductase, nifurtimox nitroreductase, oxygen-insensitive NADPH nitroreductase, nitrobenzene nitroreductase (26 Jun 1999) |
| aspartic acid 2-oxoglutarate-dependent dioxygenase | <enzyme> Hydroxylates one aspartic acid residue in the first egf-like unit of factor ix Registry number: EC 1.14.11.- Synonym: aspartate 2-oxoglutarate dioxygenase, asp-2-og-dioxygenase, aspartyl beta-hydroxylase, aspartyl (asparaginyl) beta-hydroxylase (26 Jun 1999) |
| ATP dependent 26S protease | <enzyme> Degrades proteins conjugated to ubiquitin; composed of cf-1,cf-2, and cf-3; cf-2 (also known as 240-kD proteasome inhibitor) is identical to aminolevulinic acid dehydratase Registry number: EC 3.4.99.- Synonym: 26s protease, 26 s proteasome complex, 26s proteasome (26 Jun 1999) |
| ATP-dependent DNA strand transferase | <enzyme> From human cell nuclei; catalyses strand exchange between homologous DNA sequences; magnesium dependent, requires ATP hydrolysis Registry number: EC 2.7.7.- Synonym: ATP-dep-DNA-str trnsfase (26 Jun 1999) |
| ATP-ubiquitin-dependent proteinase | <enzyme> A component of the cytosolic ubiquitin-dependent proteolysis system Registry number: EC 3.4.- Synonym: ucden (26 Jun 1999) |
| atrioventricular block | <cardiology> A conduction disturbance that results in the inappropriate delay (or complete inability) of a electrical impulse, generated in the atria, to reach the ventricles (via the atrioventricular node). Clinical types are divided into first (nonserious), second and third degree (most serious). Some drugs may precipitate atrioventricular block (for example clonidine, methyldopa, verapamil). A permanent pacemaker may be required for a third degree (complete) heart block. (02 Jan 1998) |
| autonomic nerve block | Interruption of sympathetic pathways, by local injection of an anaesthetic agent, at any of four levels: peripheral nerve block, sympathetic ganglion block, extradural block, and subarachnoid block. (12 Dec 1998) |
| autophosphorylation-dependent multifunctional protein kinase | <enzyme> A camp/ca(2+)-independent protein kinase; phosphorylates and activates phosphorylase b kinase; phosphorylates and inactivates glycogen synthase Registry number: EC 2.7.1.- Synonym: auto-kinase (26 Jun 1999) |
| A-V block | <cardiology> A conduction disturbance that results in the inappropriate delay (or complete inability) of a electrical impulse, generated in the atria, to reach the ventricles (via the atrioventricular node). Clinical types are divided into first (nonserious), second and third degree (most serious). Some drugs may precipitate atrioventricular block (for example clonidine, methyldopa, verapamil). A permanent pacemaker may be required for a third degree (complete) heart block. (02 Jan 1998) |
| block | An obstruction or stoppage. (18 Nov 1997) |